Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 26 | 2025 | 309 | 6.930 |
Why?
|
| Trypanosoma cruzi | 26 | 2025 | 251 | 6.800 |
Why?
|
| Chagas Cardiomyopathy | 6 | 2021 | 53 | 2.400 |
Why?
|
| Vaccines | 6 | 2023 | 380 | 2.010 |
Why?
|
| Facial Nerve Injuries | 5 | 2022 | 7 | 1.860 |
Why?
|
| Trypanocidal Agents | 4 | 2023 | 31 | 1.800 |
Why?
|
| Nitroimidazoles | 4 | 2023 | 44 | 1.780 |
Why?
|
| Antibodies, Protozoan | 6 | 2025 | 95 | 1.770 |
Why?
|
| Protozoan Vaccines | 11 | 2024 | 96 | 1.750 |
Why?
|
| Motor Neurons | 6 | 2022 | 136 | 1.620 |
Why?
|
| Facial Nucleus | 2 | 2022 | 2 | 1.250 |
Why?
|
| Antibody Formation | 3 | 2025 | 281 | 0.960 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2018 | 193 | 0.890 |
Why?
|
| Parasites | 2 | 2023 | 38 | 0.870 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 187 | 0.860 |
Why?
|
| Antigens, Protozoan | 5 | 2024 | 81 | 0.810 |
Why?
|
| Ascaris suum | 3 | 2020 | 32 | 0.780 |
Why?
|
| Animals | 43 | 2025 | 36557 | 0.740 |
Why?
|
| Mice | 26 | 2025 | 19055 | 0.710 |
Why?
|
| Facial Nerve | 2 | 2018 | 26 | 0.690 |
Why?
|
| Mice, Inbred BALB C | 13 | 2025 | 1089 | 0.670 |
Why?
|
| Monkey Diseases | 1 | 2020 | 18 | 0.670 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 22 | 0.650 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 45 | 0.650 |
Why?
|
| Protozoan Proteins | 4 | 2024 | 135 | 0.640 |
Why?
|
| Lymphokines | 1 | 2019 | 69 | 0.640 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 231 | 0.630 |
Why?
|
| Microbiota | 2 | 2023 | 443 | 0.610 |
Why?
|
| Protective Agents | 1 | 2018 | 36 | 0.590 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 35 | 0.570 |
Why?
|
| Immunity, Cellular | 2 | 2022 | 218 | 0.570 |
Why?
|
| HLA-B Antigens | 1 | 2018 | 31 | 0.570 |
Why?
|
| Myocardium | 2 | 2019 | 1046 | 0.550 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 825 | 0.540 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 109 | 0.530 |
Why?
|
| Ascariasis | 4 | 2020 | 73 | 0.530 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 488 | 0.520 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 629 | 0.520 |
Why?
|
| Immunologic Memory | 1 | 2018 | 200 | 0.510 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4879 | 0.480 |
Why?
|
| Vaccination | 8 | 2022 | 1017 | 0.460 |
Why?
|
| Axotomy | 3 | 2022 | 14 | 0.460 |
Why?
|
| Leishmania | 2 | 2023 | 35 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 507 | 0.400 |
Why?
|
| Leishmaniasis | 2 | 2023 | 40 | 0.400 |
Why?
|
| Nerve Regeneration | 2 | 2019 | 85 | 0.390 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4808 | 0.380 |
Why?
|
| Interleukin-10 | 3 | 2022 | 191 | 0.380 |
Why?
|
| Heart | 5 | 2023 | 749 | 0.360 |
Why?
|
| Antigens, Helminth | 5 | 2020 | 188 | 0.350 |
Why?
|
| Recombinant Proteins | 5 | 2023 | 1440 | 0.340 |
Why?
|
| Trichuriasis | 3 | 2022 | 31 | 0.340 |
Why?
|
| Immunization | 5 | 2022 | 315 | 0.330 |
Why?
|
| Female | 23 | 2025 | 71928 | 0.320 |
Why?
|
| Antibodies, Helminth | 3 | 2020 | 124 | 0.320 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 452 | 0.300 |
Why?
|
| B-Lymphocytes | 4 | 2025 | 551 | 0.280 |
Why?
|
| Fibrosis | 2 | 2019 | 463 | 0.270 |
Why?
|
| Superantigens | 2 | 2017 | 20 | 0.260 |
Why?
|
| Wallerian Degeneration | 1 | 2006 | 9 | 0.250 |
Why?
|
| Adjuvants, Immunologic | 5 | 2022 | 392 | 0.250 |
Why?
|
| Cytokines | 4 | 2022 | 1401 | 0.240 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2016 | 25 | 0.240 |
Why?
|
| RNA, Messenger | 3 | 2024 | 2915 | 0.230 |
Why?
|
| Hepatomegaly | 1 | 2023 | 22 | 0.220 |
Why?
|
| PPAR alpha | 1 | 2023 | 55 | 0.210 |
Why?
|
| Disease Progression | 3 | 2023 | 2266 | 0.210 |
Why?
|
| Leishmania mexicana | 1 | 2023 | 4 | 0.210 |
Why?
|
| Interferon-gamma | 4 | 2019 | 538 | 0.200 |
Why?
|
| Th2 Cells | 2 | 2017 | 190 | 0.190 |
Why?
|
| Neuroprotection | 1 | 2022 | 32 | 0.190 |
Why?
|
| Immunoglobulin M | 3 | 2018 | 225 | 0.190 |
Why?
|
| Th1 Cells | 2 | 2022 | 159 | 0.190 |
Why?
|
| Mutation | 2 | 2017 | 6338 | 0.190 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.190 |
Why?
|
| Metabolome | 2 | 2021 | 322 | 0.180 |
Why?
|
| Parasite Load | 2 | 2018 | 31 | 0.180 |
Why?
|
| Tropism | 1 | 2020 | 11 | 0.180 |
Why?
|
| Antigenic Variation | 1 | 2021 | 42 | 0.180 |
Why?
|
| Larva | 2 | 2018 | 262 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 2539 | 0.170 |
Why?
|
| Mexico | 2 | 2018 | 190 | 0.170 |
Why?
|
| Humans | 22 | 2024 | 134156 | 0.170 |
Why?
|
| Interleukin-17 | 1 | 2021 | 130 | 0.170 |
Why?
|
| Flow Cytometry | 2 | 2023 | 837 | 0.160 |
Why?
|
| Phospholipids | 1 | 2020 | 114 | 0.160 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 146 | 0.160 |
Why?
|
| Endothelin-1 | 1 | 2019 | 45 | 0.160 |
Why?
|
| Cysteine | 2 | 2017 | 143 | 0.160 |
Why?
|
| Parasitemia | 1 | 2019 | 26 | 0.160 |
Why?
|
| Male Urogenital Diseases | 1 | 2019 | 16 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 145 | 0.160 |
Why?
|
| Helminth Proteins | 1 | 2020 | 103 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 358 | 0.160 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2019 | 40 | 0.150 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 153 | 0.150 |
Why?
|
| Antibodies, Catalytic | 1 | 2018 | 7 | 0.150 |
Why?
|
| Swine Diseases | 1 | 2018 | 42 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 170 | 0.150 |
Why?
|
| Macaca mulatta | 1 | 2020 | 513 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 86 | 0.150 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 21 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 867 | 0.140 |
Why?
|
| Immunity | 1 | 2018 | 187 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 130 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 1627 | 0.130 |
Why?
|
| Cell Death | 1 | 2018 | 252 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2018 | 344 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2018 | 276 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 214 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1051 | 0.130 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 82 | 0.130 |
Why?
|
| Vaccines, Synthetic | 4 | 2022 | 322 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 464 | 0.130 |
Why?
|
| Trichuris | 3 | 2022 | 26 | 0.120 |
Why?
|
| Gene Frequency | 1 | 2018 | 779 | 0.120 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 169 | 0.120 |
Why?
|
| Insect Vectors | 1 | 2016 | 114 | 0.120 |
Why?
|
| Laser Capture Microdissection | 1 | 2015 | 9 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 8 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2022 | 4016 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1765 | 0.120 |
Why?
|
| Sensation Disorders | 1 | 2015 | 25 | 0.120 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 279 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 890 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2016 | 100 | 0.120 |
Why?
|
| Motor Activity | 1 | 2018 | 531 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2019 | 928 | 0.120 |
Why?
|
| Swine | 1 | 2018 | 1219 | 0.120 |
Why?
|
| Muscle Strength | 1 | 2015 | 87 | 0.110 |
Why?
|
| Acute Disease | 1 | 2018 | 1192 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 676 | 0.110 |
Why?
|
| Echocardiography | 1 | 2019 | 1132 | 0.110 |
Why?
|
| Vaccines, Combined | 2 | 2023 | 39 | 0.100 |
Why?
|
| Transfection | 1 | 2015 | 1096 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 241 | 0.100 |
Why?
|
| Histamine Release | 1 | 2012 | 11 | 0.100 |
Why?
|
| Basophils | 1 | 2012 | 13 | 0.100 |
Why?
|
| Hookworm Infections | 1 | 2014 | 123 | 0.100 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 31 | 0.100 |
Why?
|
| Necator americanus | 1 | 2012 | 89 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2017 | 752 | 0.090 |
Why?
|
| Global Health | 1 | 2016 | 622 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 1837 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 2814 | 0.090 |
Why?
|
| Immunoglobulin E | 1 | 2012 | 180 | 0.090 |
Why?
|
| HIV Infections | 1 | 2024 | 2075 | 0.090 |
Why?
|
| Lung | 1 | 2018 | 1577 | 0.090 |
Why?
|
| Male | 5 | 2020 | 66127 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1631 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2563 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2022 | 148 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3434 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2015 | 732 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 2998 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3857 | 0.070 |
Why?
|
| Leishmania major | 1 | 2007 | 27 | 0.070 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2007 | 48 | 0.070 |
Why?
|
| Pregnancy | 1 | 2020 | 7570 | 0.070 |
Why?
|
| Soil | 2 | 2020 | 72 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 65 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2023 | 806 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 2178 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 247 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 497 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 390 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 113 | 0.050 |
Why?
|
| Technology | 1 | 2024 | 71 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 724 | 0.050 |
Why?
|
| Dogs | 2 | 2016 | 798 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 402 | 0.050 |
Why?
|
| Campylobacter jejuni | 1 | 2003 | 6 | 0.050 |
Why?
|
| Campylobacter Infections | 1 | 2003 | 35 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1599 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2003 | 128 | 0.050 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 31 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 195 | 0.050 |
Why?
|
| Mice, Inbred AKR | 1 | 2022 | 14 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 521 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2022 | 92 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 138 | 0.050 |
Why?
|
| Hybridomas | 1 | 2021 | 41 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2022 | 94 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17540 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 219 | 0.040 |
Why?
|
| Synteny | 1 | 2021 | 80 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 446 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 607 | 0.040 |
Why?
|
| Colon | 1 | 2003 | 380 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 324 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 1072 | 0.040 |
Why?
|
| Aged | 1 | 2018 | 21775 | 0.040 |
Why?
|
| Neurotrophin 3 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 69 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2018 | 68 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2017 | 54 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2017 | 52 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 101 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2017 | 48 | 0.030 |
Why?
|
| Middle Aged | 1 | 2018 | 29399 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 785 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 486 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 164 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 151 | 0.030 |
Why?
|
| Coyotes | 1 | 2016 | 3 | 0.030 |
Why?
|
| Dendrites | 1 | 2018 | 204 | 0.030 |
Why?
|
| Animals, Domestic | 1 | 2016 | 33 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 119 | 0.030 |
Why?
|
| Adult | 1 | 2018 | 31945 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 54 | 0.030 |
Why?
|
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2016 | 2 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 296 | 0.030 |
Why?
|
| Triatoma | 1 | 2016 | 30 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 185 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 364 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 433 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 337 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 633 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 206 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2795 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 357 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 2045 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1310 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 277 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 609 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 440 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 449 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 417 | 0.030 |
Why?
|
| Ascaris lumbricoides | 1 | 2014 | 19 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2014 | 55 | 0.030 |
Why?
|
| Ancylostomatoidea | 1 | 2014 | 60 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2017 | 970 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2012 | 42 | 0.020 |
Why?
|
| Pichia | 1 | 2012 | 56 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3188 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2012 | 70 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 398 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 175 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1040 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2012 | 194 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2684 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 545 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3668 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11763 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3716 | 0.020 |
Why?
|
| Ear | 1 | 2007 | 27 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1621 | 0.020 |
Why?
|
| Dermis | 1 | 2007 | 27 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2007 | 125 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2007 | 100 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2669 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2007 | 399 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 367 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 13074 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1595 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3506 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 4934 | 0.010 |
Why?
|